Biogen (BIIB) had the highest return in 1995 by a US stock with a market cap of $2B+, returning 4,825.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Biogen (BIIB) | 1995 | 4,825.31% |
AutoNation (AN) | 1995 | 1,330.82% |
Onto Innovation (ONTO) | 1995 | 1,080% |
Bausch Health Companies (BHC) | 1995 | 880.94% |
Semtech (SMTC) | 1995 | 642.69% |
Regeneron Pharmaceuticals (REGN) | 1995 | 277.78% |
Alkermes (ALKS) | 1995 | 273.53% |
Match (MTCH) | 1995 | 239.04% |
IAC (IAC) | 1995 | 238.98% |
Gilead Sciences (GILD) | 1995 | 236.73% |
Ionis Pharmaceuticals (IONS) | 1995 | 228.13% |
Cadence Design Systems (CDNS) | 1995 | 207.32% |
Hexcel (HXL) | 1995 | 196.98% |
Coherent (COHR) | 1995 | 191.55% |
Boston Scientific (BSX) | 1995 | 187.59% |
Hologic (HOLX) | 1995 | 175.63% |
Quidel (QDEL) | 1995 | 171.43% |
Belden (BDC) | 1995 | 170.77% |
Cognex (CGNX) | 1995 | 169.91% |
Arrowhead Pharmaceuticals (ARWR) | 1995 | 166.67% |
Jabil Circuit (JBL) | 1995 | 164.73% |
IDEXX Laboratories (IDXX) | 1995 | 164.64% |
Jack Henry & Associates (JKHY) | 1995 | 158.05% |
Transocean (RIG) | 1995 | 154.38% |
WSFS Financial (WSFS) | 1995 | 148.29% |
